– Financial Tables to Follow –
AEHR TEST SYSTEMS AND SUBSIDIARIES | |||||||||||
Condensed Consolidated Statements of Operations | |||||||||||
(in thousands, except per share data) | |||||||||||
(unaudited) | |||||||||||
Three Months Ended | |||||||||||
Aug 31, | May 31, | Aug 31, | |||||||||
2019 | 2019 | 2018 | |||||||||
Net sales | $ | 5,533 | $ | 7,242 | $ | 4,740 | |||||
Cost of sales | 3,262 | 3,863 | 3,187 | ||||||||
Gross profit | 2,271 | 3,379 | 1,553 | ||||||||
Operating expenses: | |||||||||||
Selling, general and administrative | 1,808 | 2,018 | 1,879 | ||||||||
Research and development | 892 | 1,120 | 1,116 | ||||||||
Restructuring | - | 118 | - | ||||||||
Total operating expenses | 2,700 | 3,256 | 2,995 | ||||||||
(Loss) income from operations | (429 | ) | 123 | (1,442 | ) | ||||||
Interest income (expense), net | 12 | (24 | ) | (78 | ) | ||||||
Other income, net | 10 | 17 | 9 | ||||||||
(Loss) income before income tax expense | (407 | ) | 116 | (1,511 | ) | ||||||
Income tax expense | (6 | ) | (6 | ) | (4 | ) | |||||
Net (loss) income | (413 | ) | 110 | (1,515 | ) | ||||||
Less: Net income attributable to the noncontrolling interest | - | - | - | ||||||||
Net (loss) income attributable to Aehr Test Systems common shareholders | $ | (413 | ) | $ | 110 | $ | (1,515 | ) | |||
Net (loss) income per share | |||||||||||
Basic | $ | (0.02 | ) | $ | 0.00 | $ | (0.07 | ) | |||
Diluted | $ | (0.02 | ) | $ | 0.00 | $ | (0.07 | ) | |||
Shares used in per share calculations: | |||||||||||
Basic | 22,708 | 22,605 | 22,190 | ||||||||
Diluted | 22,708 | 22,717 | 22,190 | ||||||||